NCT00569231View on ClinicalTrials.gov

Study With Candida Antigen for Treatment of Warts

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
WartsHPV
Interventions
DRUG

Candida Antigen

Intralesional injection of 0.3ml candida antigen into largest wart at baseline visit and then every 3 weeks +/- 3 days for a maximum of 10 treatments.

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

Sponsors
All Listed Sponsors
collaborator

Allermed Laboratories, Inc.

INDUSTRY

lead

University of Arkansas

OTHER

NCT00569231 - Study With Candida Antigen for Treatment of Warts | Biotech Hunter | Biotech Hunter